State University of New York, Upstate Medical University, Syracuse, NY, USA.
Transplantation. 2012 Nov 27;94(10):988-9. doi: 10.1097/TP.0b013e318271921f.
Living kidney donor transplantation, universally recognized as the best current option in care for patients with end-stage renal disease, has shown a static growth in application in the United States despite continued expansion of the prevalent number of patients sustained by dialysis. Whether insurance providers' deficient payment to transplantation facilities for long-term costs generated by living kidney donors contributes to the problem was examined by the facility. Precise focus on all coding and billing for services rendered during care beyond 6 months effectively increased reimbursement from insurance providers for a living kidney donor from 47% to 85% of the amount billed. Although the sample of 82 donors was small and predominantly white (81.7%), it seems reasonable to suggest that centers with a low rate of payment consider an examination of their own billing and coding practices. The extent of donor resistance to participate in a continuing posttransplantation relationship with the transplantation center previously linked to financial issues borne by the donor remains unaddressed and could be explored in a subsequent study.
活体肾脏捐献移植，被普遍认为是治疗终末期肾病患者的最佳选择，尽管接受透析治疗的患者人数持续增加，但在美国的应用却一直停滞不前。该机构研究了保险提供商对移植机构为活体肾脏捐献者产生的长期费用支付不足是否导致了这一问题。通过对 6 个月以上护理期间提供的所有服务进行精确编码和计费，保险提供商对活体肾脏捐献者的报销从账单金额的 47%增加到 85%。尽管 82 名捐赠者的样本很小且主要是白人（81.7%），但似乎可以合理地推测，支付率低的中心可以考虑检查自己的计费和编码实践。捐赠者对与之前由捐赠者承担经济问题相关的移植中心建立持续的移植后关系的抵制程度仍未得到解决，这可能是一个值得在后续研究中探讨的问题。
